81. On the Pro-Metastatic Stress Response to Cancer Therapies: Evidence for a Positive Co-Operation between TIMP-1, HIF-1α, and miR-210.
Cui H, Grosso S, Schelter F, Mari B, Krüger A
Front Pharmacol. 2012 .
PMID: 22807917
82. Differential Impact of Cysteine Cathepsins on Genetic Mouse Models of De novo Carcinogenesis: Cathepsin B as Emerging Therapeutic Target.
Reinheckel T, Peters C, Krüger A, Turk B, Vasiljeva O
Front Pharmacol. 2012 .
PMID: 22798952
83. A nebulized gelatin nanoparticle-based CpG formulation is effective in immunotherapy of allergic horses.
Klier J, Fuchs S, May A, Schillinger U, Plank C, Winter G, Coester C, Gehlen H
Pharm Res. 2012 Jun .
PMID: 22302522 [PubMed - in process]
84. The use of non-viral gene vectors for bioactive poly-(D,L-lactide) implant surfaces in bone tissue engineering.
Reckhenrich AK, Koch C, Egaña JT, Plank C
Eur Cell Mater. 2012 .
PMID: 22736203
85. S100A9 a new marker for monocytic human myeloid-derived suppressor cells.
Zhao F, Hoechst B, Duffy A, Gamrekelashvili J, Fioravanti S, Manns MP, Greten TF, Korangy F
Immunology. 2012 Jun .
PMID: 22304731 [PubMed - in process]
86. Combined treatment of L1CAM antibodies and cytostatic drugs improve the therapeutic response of pancreatic and ovarian carcinoma.
Schäfer H, Dieckmann C, Korniienko O, Moldenhauer G, Kiefel H, Salnikov A, Krüger A, Altevogt P, Sebens S
Cancer Lett. 2012 Jun 1.
PMID: 22210381 [PubMed - in process]
87. Regulatory T cells use programmed death 1 ligands to directly suppress autoreactive B cells in vivo.
Gotot J, Gottschalk C, Leopold S, Knolle PA, Yagita H, Kurts C, Ludwig-Portugall I
Proc Natl Acad Sci U S A. 2012 Jun 26.
PMID: 22689978 [PubMed - in process]
88. Optimizing adenoviral transduction of endothelial cells under flow conditions.
Anton M, Wolf A, Mykhaylyk O, Koch C, Gansbacher B, Plank C
Pharm Res. 2012 May .
PMID: 22207207 [PubMed - in process]
89. Lack of PPARγ in myeloid cells confers resistance to Listeria monocytogenes infection.
Abdullah Z, Geiger S, Nino-Castro A, Böttcher JP, Muraliv E, Gaidt M, Schildberg FA, Riethausen K, Flossdorf J, Krebs W, Chakraborty T, Kurts C, Schultze JL, Knolle PA, Klotz L
PLoS One. 2012 .
PMID: 22629382 [PubMed - in process]
90. Human CCR4+ CCR6+ Th17 cells suppress autologous CD8+ T cell responses.
Zhao F, Hoechst B, Gamrekelashvili J, Ormandy LA, Voigtländer T, Wedemeyer H, Ylaya K, Wang XW, Hewitt SM, Manns MP, Korangy F, Greten TF
J Immunol. 2012 Jun 15.
PMID: 22615204 [PubMed - in process]